CONMED (NYSE:CNMD) Given New $120.00 Price Target at Stifel Nicolaus
CONMED (NYSE:CNMD – Free Report) had its target price lowered by Stifel Nicolaus from $136.00 to $120.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities research analysts have also recently commented on the company. Piper Sandler raised their […]
More Stories
US Issues License for Oil and Gas Exploration in Venezuela
By Jill McLaughlin The U.S. Treasury Department issued a general license on Feb. 10 authorizing the exploration, development, and production...
Small Business Administration Suspends 111,620 California Borrowers Suspected of $8.6 Billion Fraud
By Naveen Athrappully The Small Business Administration (SBA) has suspended 111,620 California borrowers suspected of committing fraudulent activity related to...
Freight Data Indicate Early US Industrial Rebound as Midwest Truck Volumes Jump
By Tom Ozimek U.S. freight markets are showing signs of a shift toward domestically driven industrial activity, with truckload volumes...
Musk Offers Legal Fees for Anyone Sued Who ‘Speaks the Truth’ About Epstein
By Rachel Roberts Tech billionaire Elon Musk said he will pay the legal fees of anyone who speaks out about...
FBI Releases New Images of Potential Suspect in Nancy Guthrie Kidnapping
By Zachary Stieber The FBI on Feb. 10 released new images and videos showing a person outside the home of...
UK PM Starmer’s Communications Director Quits Over Mandelson–Epstein Scandal
By Owen Evans British Prime Minister Keir Starmer’s communications director, Tim Allan, resigned on Feb. 9, a day after Chief...